Neoadjuvant chemotherapy (NACT) increases immune infiltration and programmed death-ligand 1 (PD-L1) expression in epithelial ovarian cancer (EOC).
Mesnage SJL, Auguste A, Genestie C, Dunant A, Pain E, Drusch F, Gouy S, Morice P, Bentivegna E, Lhomme C, Pautier P, Michels J, Le Formal A, Cheaib B, Adam J, Leary AF.
Mesnage SJL, et al. Among authors: pautier p.
Ann Oncol. 2017 Mar 1;28(3):651-657. doi: 10.1093/annonc/mdw625.
Ann Oncol. 2017.
PMID: 27864219
Free article.